Terms: = Colorectal cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572
14 results:
1. MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in colorectal cancer via Epigenetically Silencing TPM1.
Li C; Hong S; Hu H; Liu T; Yan G; Sun D
Mol Cancer Res; 2022 Nov; 20(11):1697-1708. PubMed ID: 35857351
[TBL] [Abstract] [Full Text] [Related]
2. circIFITM1/miR-802/foxp1 Axis Participates in Proliferation and Invasion of Lovo Cells.
Wan Y; He J; Han Z; Wang S; Zhao Y; Zeng D; Tang Y; He Y; Zeng L
Dis Markers; 2022; 2022():7366337. PubMed ID: 35783017
[TBL] [Abstract] [Full Text] [Related]
3. Whole-exome sequencing analysis of NSCLC reveals the pathogenic missense variants from cancer-associated genes.
Kumar S U; Balasundaram A; Cathryn R H; Varghese RP; R S; R G; Younes S; Zayed H; Doss C GP
Comput Biol Med; 2022 Sep; 148():105701. PubMed ID: 35753820
[TBL] [Abstract] [Full Text] [Related]
4. Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer.
Chodary Khameneh S; Razi S; Shamdani S; Uzan G; Naserian S
Sci Rep; 2022 Feb; 12(1):2990. PubMed ID: 35194111
[TBL] [Abstract] [Full Text] [Related]
5. colorectal cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
Front Immunol; 2021; 12():778329. PubMed ID: 34975867
[TBL] [Abstract] [Full Text] [Related]
6. Altered Expression of MBNL Family of Alternative Splicing Factors in colorectal cancer.
Navvabi N; Kolikova P; Hosek P; Zitricky F; Navvabi A; Vycital O; Bruha J; Palek R; Rosendorf J; Liska V; Pitule P
Cancer Genomics Proteomics; 2021; 18(3):295-306. PubMed ID: 33893082
[TBL] [Abstract] [Full Text] [Related]
7. foxp1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
[TBL] [Abstract] [Full Text] [Related]
8. A novel epigenetic regulation of circfoxp1 on foxp1 in colon cancer cells.
Luo Y; Liu F; Ma J; Fu Y; Gui R
Cell Death Dis; 2020 Sep; 11(9):782. PubMed ID: 32951006
[TBL] [Abstract] [Full Text] [Related]
9. CASC21, a foxp1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6.
Gong T; Li Y; Feng L; Fang M; Dai G; Huang X; Yang Y; Liu S
Aging (Albany NY); 2020 Jun; 12(12):12086-12106. PubMed ID: 32584787
[TBL] [Abstract] [Full Text] [Related]
10. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract] [Full Text] [Related]
11. Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer.
Wang G; Wang Q; Huang Q; Chen Y; Sun X; He L; Zhan L; Guo X; Yin C; Fang Y; He X; Xing J
Int J Cancer; 2019 May; 144(10):2516-2528. PubMed ID: 30415472
[TBL] [Abstract] [Full Text] [Related]
12. Expression of foxp1 and colorectal cancer Prognosis.
De Smedt L; Palmans S; Govaere O; Moisse M; Boeckx B; De Hertogh G; Prenen H; Van Cutsem E; Tejpar S; Tousseyn T; Sagaert X
Lab Med; 2015; 46(4):299-311. PubMed ID: 26489674
[TBL] [Abstract] [Full Text] [Related]
13. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract] [Full Text] [Related]
14. New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma.
Adams H; Tzankov A; Lugli A; Zlobec I
J Clin Pathol; 2009 Nov; 62(11):986-97. PubMed ID: 18977805
[TBL] [Abstract] [Full Text] [Related]
